Boehringer Ingelheim's R&D expenditure as a percentage of revenue 2004-2018

This statistic shows Boehringer Ingelheim's expenditure on research and development as a percentage of revenues between 2004 and 2018. In 2018, 18.1 percent of the company's total revenues were issued on research and development. The Boehringer Ingelheim group is one of the world's top 20 pharmaceutical companies. The company is headquartered in Ingelheim, Germany.

Boehringer Ingelheim's expenditure on research and development as a percentage of revenue from 2004 to 2018

Percentage of revenue
201818.1%
201717%
201619.6%
201520.3%
201419.9%
201319.5%
201219%
201119.1%
201019.5%
200917.4%
200818.2%
200717.3%
200614.9%
200514.3%
200415.1%
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

April 2019

Region

Worldwide

Survey time period

2004 to 2018

Supplementary notes

This statistic was assembled from several annual reports.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.